I. Introduction
T HE menopause occurs at approximately 51 yr of age in women and signals the permanent end of fertility. Interests in understanding the mechanisms that regulate the timing and the repercussions of this profound "change of life" have increased greatly during the past 10 yr for several reasons. First, during this century, the average life span of humans has increased dramatically; however, the age of the menopause has remained fixed. Thus, an increasing number and proportion of women will live a larger fraction of their lives in the postmenopausal state than ever before. Second, a hallmark of the postmenopausal period is the total exhaustion of ovarian follicles and the resulting virtual absence of ovarian steroids and peptides. We now realize that estrogen modulates a far broader array of functions than was once appreciated. In addition to its important effects within the reproductive axis, new findings suggest that this pleiotropic hormone plays novel and important roles in functions that were considered traditionally as "nonreproductive," including modulation of bone and mineral metabolism (1) , cardiac and vascular function (2) , and cognition and memory (3, 4) and the risk and progression of age-related neurodegenerative diseases (5) (6) (7) . Therefore, the repercussions of the profound decrease in ovarian steroids are likely to be much broader than we imagined. Third, we are beginning to understand that the transition to acyclicity may not be triggered simply by decreasing ovarian estrogen, but by an interacting constellation of ovarian and neuroendocrine events that exacerbates the rate of loss of the ovarian follicular reserve and leads to decreasing fertility and fecundity and irregular reproductive cycles. Because such a long period in a woman's life is spent in this hypoestrogenic state and because this impacts on the status of so many physiological systems, it is critical that we deepen our understanding of the complex interplay of factors that leads to the transition to the postmenopausal state; this will enable us to develop the means to treat some of the repercussions of the declining reproductive system and answer fundamental questions about the process of aging.
We should point out that many studies on reproductive aging that are cited in this review have been performed in animal models, particularly laboratory rodents. By definition, these species do not undergo the "menopause," since they never experience "menses" during their reproductive life. Some investigators believe that fundamental differences exist between primates and rodents in the control of reproductive cyclicity and infer that aging involves completely different mechanisms between these species. However, we believe that important commonalities in the hypothalamic control of ovarian function exist between primates and rodents. Therefore, we believe that rodents are excellent experimental models and have provided key insights into the mechanisms and factors that regulate development of the reproductive system, puberty, and maintenance of regular cycles in the adult. We are confident that information gained from studies performed in these species will allow us to develop concepts that can also be applied to human reproductive aging.
II. Interplay Between the Ovary and Brain in Reproductive Senescence
For many years, it was accepted that the menopause resulted simply from exhaustion of ovarian follicles; changes in other components of the reproductive axis that accompany the menopause were considered merely consequences of declining ovarian function. More recently, increasing attention has been paid to the possibility that age-related changes in the hypothalamus and central nervous system are important players in the ensemble of events that lead to the menopause: exhaustion of ovarian follicles may be accelerated as a consequence of desynchronization of neural signals. We are beginning to appreciate that before ovarian follicles are exhausted, fertility and fecundity decrease markedly, reproductive cycles become increasingly irregular in length, and patterns of gonadotropin secretion are altered. Newer findings encourage us to reevaluate the simple model of ovarian aging and to consider the possibility that a more complex series of simultaneous changes interact with each other, leading to the menopause. To understand the pacemakers that trigger the cascade of events leading to the transition to the menopausal state, investigators have increasingly turned their attention to the period before the establishment of permanent acyclicity, i.e., the events that occur during the fourth decade of life in women (8 -10) or the equivalent stage in experimental animal models (11) (12) (13) (14) (for reviews see Refs. 15 and 16) .
The concept that senescence of the ovary is the primary cause of the menopause results from our knowledge that women are born with a finite, nonrenewable, postmitotic pool of dormant follicles (17) . From the time that follicles are formed during prenatal development, each day a number of dormant primordial follicles reawaken and begin to grow and differentiate. The vast majority of these growing follicles undergo cell death during development, presumably because the appropriate hormonal environment does not exist to nurture continued development and final stages of differentiation. When women reach middle age, the rate of loss of follicles remaining in the ovary doubles, accelerating the time of eventual total depletion of the follicular reserve (18, 19) . Knowledge about whether or not patterns of hormone secretion change during the menopause and why they change may help us to understand the increasing rate of follicular loss that occurs just before the menopausal transition.
III. Neuroendocrine Contributions to the Menopause
The concept that the central nervous system, and the hypothalamus in particular, regulates the timing of the menopause follows from our understanding, derived from studies performed largely in animal models, that during aging the neurochemical and neuroendocrine signals that dictate the patterns of secretion of the gonadotropins, which, in turn, govern the development of follicles, become less precise and synchronized (20, 21) . Newer data, primarily from recent studies performed in women during the perimenopausal period, reveal that striking parallel changes may occur in humans. Clearly, the methods that can be used to assess the status of neuroendocrine axis in humans are more indirect than the experimental approaches that can be used in laboratory animals. We will discuss first the results of studies performed in laboratory animals and then those performed in women.
Some of the earliest evidence that the hypothalamus plays a role in reproductive aging comes from classic studies using two experimental approaches. First, transplantation of ovaries of old animals to the kidney capsule of young, regularly cycling, but previously ovariectomized females hosts, revealed that follicular development and ovulation occurred under the influence of the young neuroendocrine environment. This demonstrates that depletion of ovarian oocytes is not the cause of the acyclic state (21, 22) . Later studies that examined the ability of grafts to restore cyclicity during middle age concluded that the neuroendocrine axis may contribute predominantly to the transition from regular cycles to irregular cycles, while the ovary contributes to the ultimate cessation of cycles (23) . Second, administration of drugs that restore hypothalamic monoaminergic activity or electrochemical stimulation of the preoptic area of the hypothalamus of old female rats reinstated LH surges, estrous cyclicity, and ovulation (24 -26) . These results indicate that changing hypothalamic function contributes to age-related reproductive decline. More recent studies, which focus attention on the middle age transition period, suggest that hypothalamic changes, albeit subtle, may contribute to the onset of irregular cycles that ultimately lead to acyclicity (for review see Ref. 16 ).
It would be optimal to measure plasma GnRH secretion to critically test whether the dynamics of GnRH secretion are altered during or after the onset of the perimenopausal transition. Unfortunately, at the present time, GnRH cannot be measured in the peripheral blood of humans because assays are not sufficiently sensitive. In fact, even in animal models, where it is possible to measure GnRH in the hypophyseal portal blood using invasive methods, it is impossible to perform these studies over several months, which would be required in aging studies. Therefore, the only alternative is to measure FSH and LH as indirect indices of GnRH secretion. Numerous reports clearly establish that the patterns of secretion of both gonadotropins are altered during middle age in rodent models and are thought to reflect, in large part, changes in the ability of GnRH neurons to maintain normal patterns of secretion. One of the earliest signs of the impending transition to irregular cyclicity is an increase in FSH concentrations, which are particularly evident during the secondary FSH surge that occurs on estrus (12) . This increase has been attributed to decreased inhibin activity measured in the ovarian vein. However, we should keep in mind that the patterns of gonadotropin secretion and the relative amounts of FSH and LH are driven, in part, by the pattern of secretion of GnRH. In fact, a selective rise in FSH secretion can be achieved by slowing the frequency of GnRH pulses (27) . Therefore, both the hypothalamus and the ovary may contribute to the selective rise in FSH levels in middle-aged rats. Both the preovulatory surge and the pulsatile secretion of LH are altered during middle age: the preovulatory LH surge is delayed and attenuated (13, 28, 29) , and the interpulse interval and average duration of individual pulses of LH (11) increase with age ( Figs. 1 and 2 ). Changes in these two parameters of LH secretion are thought to reflect more purely changes in the hypothalamic pulse generator and the accuracy with which it generates discrete, robust signals. Therefore, these data are particularly provocative and lend credence to the possibility that subtle changes in the neurochemical inputs and/or the integrity of the GnRH pulse generator occur early, before the transition from regular to irregular cycles, and may be a component of the cascade of events that contribute to reproductive aging.
An interest in exploring the possibility that neuroendocrine alterations may play a role in the transition to irregular menstrual cycles in women has been bolstered by recent reports that estradiol levels do not decrease but, in fact, increase in middle-aged cycling women (10) (Fig. 3) and that menstrual cycles lengthen during the perimenopausal period (30) . Since these changes are similar to those reported in middle-aged rodents, they have led investigators to reexam- ine more closely the neuroendocrine alterations in women as they enter the perimenopausal period. Recent studies clearly reveal strikingly similar changes in the pattern of FSH and LH secretion in middle-aged women before any change in menstrual cycle length. As in rodent models, a selective rise in FSH secretion heralds the imminent transition to irregular menstrual cycles (8, 31, 32) (Fig. 4) . In addition, significant increases in the interpulse interval and the duration of individual LH pulses have been reported in regularly cycling middle-aged women during the mid to late follicular phase of the menstrual cycle when plasma estradiol levels were normal and FSH concentrations were elevated (9) (Fig. 5) . It is important to note that some studies report no change or increases in LH pulse frequency (33) . Thus, the ability to detect changes may depend upon the times of the cycle that were monitored or whether the length of the menstrual cycle has changed in the women that were included in the study. Furthermore, the incidence of hot flushes and sleep disturbances, both indirect indices of hypothalamic function, become evident in women between the ages of 35-40, at the same time that the rate of follicular loss accelerates (15 
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Together, these data suggest that the initial alterations in the hypothalamic-pituitary axis precede the loss of regular cyclicity in women, as well as in rodent models. Accumulating evidence suggests that deterioration in the coupling of neurotransmitter signals that regulate GnRH secretion or an uncoupling of the composite of neurochemical signals from GnRH neurons causes the initial changes in patterns of gonadotropin secretion. The recurring and pervasive feature of these initial neurochemical changes is that their daily rhythmicity is affected far more frequently than their overall average level of activity or expression (Fig. 6) . The finding that the rhythmicity of so many neurotransmitters change during aging has led to the hypothesis that deterioration of the "biological clock" or its ability to communicate with efferents that communicate with GnRH neurons leads to alterations in the pattern of gonadotropin secretion. In mammals, the suprachiasmatic nuclei are considered the master circadian pacemaker because these nuclei not only exhibit 24-h rhythmicity themselves, but they communicate extensively with many regions of the brain and drive the timing of multiple outputs. The impact of this is so great that virtually all physiological functions show a pervasive daily rhythm (34) . The reproductive cycle is fundamentally grounded upon a circadian foundation. This is most evident in rodents that are maintained in controlled laboratory conditions. However, even in human populations where activity, light-dark cycles, and sleep are not rigorously controlled by experimental protocols, reproductive functions exhibit a diurnal rhythmicity (35) . In animal models, the expression and rhythmicity of some of the neuropeptides of the suprachiasmatic nucleus that project to GnRH neurons decrease with age (36) , and the rhythmicity of several neurotransmitters that are driven by the clock deteriorate with age (16) . Thus, a fundamental deterioration in the neural pacemaker or the coupling to its outputs may initiate the gradual disintegration of the temporal organization of neurotransmitter rhythms that are critical for stable, precise, and regular cyclic LH secretion. This may initiate a cascade that leads to the transition to irregular cycles and ultimately contributes to acyclicity.
IV. Neuroendocrine Repercussions of the Menopause
One of the most exciting areas of research in women's health over the past 10 yr involves our growing appreciation that estrogen plays important neurotrophic and neuroprotective roles during adulthood. This brings new meaning to the potential impact of the prolonged postmenopausal, hypoestrogenic state on learning and memory and the potential increased vulnerability of aging women to brain injury (37) and neurodegenerative diseases (3, 4, 6, 38, 39) .
Studies using animal models reveal that estradiol exerts neurotrophic actions as measured by induction of neurite outgrowth, dendritic spines, and synaptogenesis, influence on long-term potentiation and excitability, and enhancement of gene expression (for review see Ref. 40) . These effects can be replicated in in vitro dispersed neuronal cell cultures (41) . Estrogen also exerts neuroprotective actions in in vivo and in vitro models of brain injury. Animal models of stroke or cardiac arrest provide convincing evidence that estradiol is a neuroprotective factor. Females consistently sustain less brain injury than males, and estrogen treatment decreases ischemic injury in both sexes (42) (43) (44) ; furthermore, replacement with estrogen protects against ischemic injury in castrated males and females (45) (46) (47) (Fig. 7) . In addition, multiple studies have shown that estrogen can protect against injury induced by a variety of toxic stimuli (48 -51) .
Findings suggest that the trophic and protective effects of estrogen may be mediated via multiple cellular and molecular mechanisms. It may act via classic genomic mechanisms on a variety of genes including the neurotrophins and their receptors, cell death proteins and/or structural proteins that allow maintenance of synapses and neurite outgrowth. In addition, there is accumulating evidence that estrogen exerts its effects by novel mechanisms that are different from the well characterized mechanism involving transactivation, nu- (50, (53) (54) (55) (56) (57) . Estrogen may act through novel mechanisms that include cross-talk with other second messenger systems, such as cAMP (54, 58) or mitogen-activated protein kinases (55) . Some of these novel mechanisms of estrogen action may require cross-talk with the estradiol receptor; however, which receptor subtype (␣ or ␤) is involved is unclear. Whether ligand-bound receptors must bind to classic estrogen response elements to evoke protection and growth is also unclear. Other trophic and protective effects of estrogen occur in the absence of any known intracellular estrogen receptor (51) and are detectable within minutes. This strongly suggests that estrogens may act either on a membrane receptor that has not yet been isolated or characterized or may act by influencing membrane receptors that are linked to ion channels (59, 60) .
V. Summary
In summary, the evidence that both the ovary and the brain are key pacemakers in the menopause is compelling. Our appreciation that estrogens are important neurotrophic and neuroprotective factors has grown rapidly. Future studies will allow us to better understand the ensemble of factors that interact to maintain regular reproductive cyclicity and how this precise dynamic balance changes with age. Furthermore, understanding how estrogen exerts trophic and protective actions should lead to its use as an important therapeutic agent in the maintenance of normal neural function during aging and after injury. 
